Home › Funds › Candriam S.C.A. › MCK
Candriam S.C.A. position in MCK
MCKESSON CORP · Health Care
Candriam S.C.A. reported holding 206,756 shares of MCK (MCKESSON CORP) in its Q3 2026 13F filing — a position valued at US$177.2M, representing 0.80% of its reported portfolio and ranking #23 among its reported holdings. Candriam S.C.A. has disclosed MCK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Candriam S.C.A.'s MCK position evolved
Candriam S.C.A. first disclosed a stake in MCK in Q3 2023 at 37,091 shares (US$16.1M). The position peaked in Q1 2026 at 239,664 shares, worth US$207.4M. Across 13 filings, Candriam S.C.A. increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 206,756 shares valued at US$177.2M — a reduction of -3,654 shares quarter over quarter.. Notable position changes include a 30% increase in Q4 2023 (shares rose 16% over the following quarter), a 135% increase in Q1 2024 (shares rose 9% over the following quarter), a 26% increase in Q3 2025 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 37.09K | $16.13M | New |
| Q4 2023 | 48.17K | $22.30M | Add |
| Q1 2024 | 113.05K | $60.69M | Add |
| Q2 2024 | 86.93K | $50.77M | Reduce |
| Q3 2024 | 85.47K | $42.25M | Reduce |
| Q4 2024 | 106.89K | $60.92M | Add |
| Q1 2025 | 121.40K | $81.70M | Add |
| Q2 2025 | 150.60K | $110.36M | Add |
| Q3 2025 | 190.19K | $146.93M | Add |
| Q4 2025 | 205.29K | $168.41M | Add |
| Q1 2026 | 239.66K | $207.40M | Add |
| Q2 2026 | 210.41K | $158.83M | Reduce |
| Q3 2026 | 206.76K | $177.18M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MCK and 13F data
MCK (MCKESSON CORP) is a Health Care company. 34 other funds we track also report a position in MCK — the largest reported positions include Franklin Resources (US$3.09B), ALLIANCEBERNSTEIN L.P. (US$1.46B), MFS Investment Management (US$1.33B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MCK
- Franklin Resources 2.89M sh · $3.09B · Q3 2026
- ALLIANCEBERNSTEIN L.P. 1.69M sh · $1.46B · Q2 2026
- MFS Investment Management 1.55M sh · $1.33B · Q3 2026
- Arrowstreet Capital 1.55M sh · $1.17B · Q2 2026
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 1.54M sh · $1.16B · Q2 2026
- Boston Partners 1.18M sh · $1.01B · Q3 2026
- Goldman Sachs Group 1.32M sh · $998.25M · Q2 2026
- ROYAL BANK OF CANADA 1.28M sh · $969.67M · Q2 2026
- NORDEA INVESTMENT MANAGEMENT AB 1.03M sh · $890.23M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 999.99K sh · $864.81M · Q3 2026
- Manulife Financial 862.18K sh · $651.46M · Q2 2026
- Swedbank AB 740.86K sh · $632.55M · Q3 2026
More on Candriam S.C.A.
FAQ
How long has Candriam S.C.A. held MCK?
Candriam S.C.A. has disclosed MCK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Candriam S.C.A.'s current position in MCK?
As of Q3 2026, Candriam S.C.A. holds 206.76K shares of MCK (MCKESSON CORP), valued at $177.18M, representing 0.80% of its reported portfolio and ranking #23.
Has Candriam S.C.A. been buying or selling MCK?
In the latest 13F filing (Q3 2026), Candriam S.C.A. reduced its position in MCK. The position peaked in Q1 2026 at 239.66K shares.
Which other funds hold MCK?
Other major institutional holders of MCK include Franklin Resources, ALLIANCEBERNSTEIN L.P., MFS Investment Management, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.